Synchron

Synchron is a leader in the field of implantable neural interface technology. The company's neuroprosthetics have entered the clinical stage for the treatment of paralysis and are developing the first intravascular implantable neuromodulation therapy. Future applications may include the potential to diagnose and treat neurological disorders, including Parkinson's disease, epilepsy, depression, and hypertension, as well as non-medical solutions.